483
Laurie Mereu, MDLaurie Mereu, MD – FDA 483
Record Details
An FDA inspection of the Division of Endocrinology & Metabolism, Dept. of Medicine in Edmonton, AB, Canada, from July 18-22, 2016, revealed that an investigation was not conducted in accordance with the investigational plan. Specifically, subjects were randomized into a study without the most recent serum creatinine and eGFR results, and temperature monitoring for clinical supplies storage was not consistently performed over several months.
- Company
- Laurie Mereu, MD
- Product type
- drugs
View Company Profile
ID · 2c02f04c-2b64-4928-8157-2e6c5a09363e
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.